A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
Launched by SHAMAN PHARMACEUTICALS · Aug 30, 2001
Trial Information
Current as of March 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- Patients must have:
- • HIV infection meeting CDC criteria for AIDS.
- • History of diarrhea for greater than or equal to 14 days prior to screening period (Day 1).
- Required:
- • - On stable medical regimen.
About Shaman Pharmaceuticals
Shaman Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of innovative therapies derived from traditional medicinal plants. With a focus on leveraging cutting-edge research and advanced drug formulation techniques, Shaman Pharmaceuticals aims to address unmet medical needs across various therapeutic areas. The company is committed to rigorous clinical trial methodologies and regulatory compliance, ensuring the safety and efficacy of its products while fostering collaborations with academic institutions and industry partners to enhance its research capabilities and drive sustainable growth.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Boston, Massachusetts, United States
San Francisco, California, United States
Baltimore, Maryland, United States
Washington, District Of Columbia, United States
Indianapolis, Indiana, United States
Kenner, Louisiana, United States
Maitland, Florida, United States
Scottsdale, Arizona, United States
Tampa, Florida, United States
St. Paul, Minnesota, United States
West Hollywood, California, United States
St. Louis, Missouri, United States
Scottsdale, Arizona, United States
Palo Alto, California, United States
West Hollywood, California, United States
Washington, District Of Columbia, United States
Coral Gables, Florida, United States
Miami, Florida, United States
Orlando, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Decatur, Georgia, United States
Oak Park, Illinois, United States
Detroit, Michigan, United States
Minneapolis, Minnesota, United States
Brooklyn, New York, United States
New York, New York, United States
Raleigh, North Carolina, United States
Houston, Texas, United States
San Antonio, Texas, United States
San Antonio, Texas, United States
Seattle, Washington, United States
Seattle, Washington, United States
Ponce, , Puerto Rico
San Juan, , Puerto Rico
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials